Alterations induced in vitro by ochratoxin A in rat lymphoid cells

Human and Experimental Toxicology

Volumn 24, Issue 9, 2005, Pages 459-466

  Alvarez Erviti, L ^a   Leache, C ^a   Gonzalez Penas E ^a   López De Cerain, Adela ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Apoptosis; Immunotoxicity; in vitro; Ochratoxin A; Phenylalanine; Piroxicam

Indexed keywords

CONCANAVALIN A; LIPOPOLYSACCHARIDE; OCHRATOXIN; PHENYLALANINE; PIROXICAM; PROSTAGLANDIN;

AEROBIC METABOLISM; ANIMAL CELL; APOPTOSIS; ARTICLE; BACTERIOLYSIS; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOTOXICITY; LIGHT DARK CYCLE; LYMPHOCYTE PROLIFERATION; LYMPHOID CELL; MACROPHAGE; MALE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; RAT;

ANIMALS; APOPTOSIS; CELLS, CULTURED; CONCANAVALIN A; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; KILLER CELLS, NATURAL; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MACROPHAGES; MALE; MYCOTOXINS; OCHRATOXINS; PHENYLALANINE; PIROXICAM; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, WISTAR; T-LYMPHOCYTES, CYTOTOXIC;

ANIMALIA; ASPERGILLUS; PENICILLIUM;

EID: 26444442354     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/0960327105ht554oa     Document Type: Article

References (43)

1. Walker R. Risk assessment of ochratoxin A: current views of the European Scientific Committee on Food, the JECFA and the Codex Committee on Food Additives and Contaminants. Adv Exp Med Biol 2002; 504: 249-55.
2. Kuiper-Goodman T, Scott PM. Risk assessment of the mycotoxin ochratoxin A. Biomed Environ Sci 1989; 2: 179-248.
3. Bozic Z, Duancic V, Belicza M, Kraus O, Skljarov I. Balkan endemic nephropathy: still a mysterious disease. Eur J Epidemiol 1995; 11: 235-38.
4. Plestina R. Nephrotoxicity of ochratoxin A. Food Addit Contain 1996; 13: 49-50.
5. IARC. Ochratoxin A. Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. IARC monographs on the evaluation of carcinogenic risks to humans 1993; 56: 489-521.
6. FAO/WHO. Evaluation of certain food additives and contaminants. Forty-fourth report. WHO Technical report series n 859, 1995: 35-36.
7. Commission Regulation (EC) No 472/2002 of 12 March 2002 amending Regulation (EC) No 466/2001 setting maximum levels for certain contaminants in foodstuffs (Text with EEA relevance. Official Journal L 075, 16/03/2002: 18-20.
8. Commission Regulation (EC) No 683/2004 of 13 April 2004 amending Regulation (EC) No 466/2001 as regards aflatoxins and ochratoxin A in foods for infants and young children Official Journal L 106, 15/04/2004: 3-5.
9. Lea T, Steien K, Stormer FC. Mechanism of ochratoxin A-induced immunosuppression. Mycopathologia 1989; 107: 153-59.
10. Stormer FC, Lea T. Effects of ochratoxin A upon early and late events in human T-cell proliferation. Toxicology 1995; 95: 45-50.
11. Haubeck HD, Lorkowski G, Kölsch E, Röschthaler R. Immunosuppression by ochratoxin A and its prevention by phenylalanine. Appl Environ Microbiol 1981; 41: 1040-42.
12. Creppy EE, Stormer FC, Röschenthaler R, Dirheimer G. Effects of two metabolites of ochratoxin A, (4R)-4-hydroxyochratoxin A and ochratoxin alfa, on immune response in mice. Infect Immun 1983; 39: 1015-18.
13. Müller G, Kielstein H, Kohler H, Berndt A, Rosner H. Studies of the influence of ochratoxin A on immune and defence reactions in the mouse model. Mycoses 1995; 38: 85-91.
14. Thuvander A, Breitholtz-Emanuelsson A, Olsen M. Effects of ochratoxin A on the mouse immune system after subchronic exposure. Food Chem Toxicol 1995; 33: 1005-11.
15. Luster MI, Germolec DR, Burleson GR, Jameson CW, Ackermann MF, Lamm KR, Hayes HT. Selective immunosuppression in mice of natural killer cell activity by ochratoxin A. Cancer Res 1987; 47: 2259-63.
16. Boorman GA, Hong HL, Dieter MP, Hates HT, Pohland AE. Myelotoxicity and macrophage alteration in mice exposed to ochratoxin A. Toxicol Appl Pharmacol 1984; 72: 304-12.
17. Hong HH, Jameson CW, Boorman GA. Residual hematopoietic effect in mice exposed to ochratoxin A prior to irradiation. Toxicology 1988; 53: 57-67.
18. Dortant PM, Peters-Volleberg GWM, Van Loveren H, Marquardt RR, Speijers GJA. Age-related differences in the toxicity of ochratoxin A in female rats. Food Chem Toxicol 2001; 39: 55-65.
19. Alvarez L, Gil AG, Ezpeleta O, García-Jalón JA, Lopez de Cerain A. Immunotoxic effects of ochratoxin A in Wistar rats after oral administration. Food Chem Toxicol 2004; 42: 825-34.
20. Chang CF, Hamilton PB. Impairment of phagocytosis by heterophils from chickens during ochratoxicosis. Appl Environ Microbiol 1980; 39: 572-75.
21. Campbell ML, May JD, Huff WE, Doerr JA. Evaluation of immunity of young broiler chickens during simultaneous aflatoxicosis and ochratoxicosis. Poultry Sci 1983; 62: 2138-44.
22. Dwivedi P, Burns RB. Pathology of ochratoxicosis A in young broiler chicks. Res Vet Sci 1984; 36: 92-103.
23. Harvey RB, Elissalde MH, Kubena LF, Weaver EA, Corrier DE, Clement BA. Immunotoxicity of ochratoxin A to growing gilts. Am J Vet Res 1992; 53: 1966-70.
24. Stormer FC, Storen O, Hansen CE, Pedersen JI, Aasen AJ. Formation of (4R)-and (4S)-4-hydroxyochratoxin A and 10-hydroxyochratoxin A from ochratoxin A by rabbit liver microsomes. Appl Environ Microbiol 1983; 45: 1183-87.
25. Creppy EE, Kern D, Steyn PS, Vleggaar R, Röschenthaler R, Dirheimer G. Comparative study of the effect of ochratoxin A analogues on yeast aminoacyl-tRNA synthetases and on the growth and protein synthesis of hepatoma cells. Toxicol Lett 1983; 19: 217-24.
26. L. Toxicol Sci 2004; 79: 335-44.
27. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W eds. Current protocols in immunology. New York: Greene Publishing and Wiley Interscience, 1991.
28. Vollenweider I, Groscurth P. Comparison of four DNA staining fluorescence dyes for measuring cell proliferation of lymphokine-activated killer (LAK) cells. J Immunol Methods 1992; 149: 133-35.
29. 51Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 1968; 14: 181-96.
30. Muchmore AV, Nelson DL, Kirschner H, Blaese RM. A reappraisal of the effector cells mediating mitogen induced cellular cytotoxicity. Cell Immunol 1975; 19: 78-90.
31. Peck R. A one-plate assay for macrophage bactericidal activity. J Immunol Methods 1985; 82: 131-40.
32. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
33. Jiménez AM, López de Cerain A, González-Peñas E, Bello J. A high-performance liquid-chromatographic method for the determination of ochratoxin A in human plasma. Chromatographia 1999; 50: 457-60.
34. Konrad I, Röschenthaler R. Inhibition of phenylalanine tRNA synthetase from Bacillus subtilis by ochratoxin A. FEBS Lett 1977; 83: 341-47.
35. Creppy EE, Lugnier AJ, Beck G, Röschenthaler R, Dirheimer G. Action of ochratoxin A on cultured hepatoma cells-reversion of inhibition by phenylalanine. FEBS Lett 1979; 104: 287-90.
36. Rahimtula AD, Béréziat JC, Bussacchini-Griot V, Bartsch H. Lipid peroxidation as a possible cause of ochratoxin A toxicity. Biochem Pharmacol 1988; 37: 4469-77.
37. Omar RF, Rahimtula AD, Bartsch H. Role of cytochrome P-450 in ochratoxin A-stimulated lipid peroxidation. J Biochem Toxicol 1991; 6: 203-209.
38. Baudrimont I, Murn M, Betbeder AM, Guilcher J, Creppy EE. Effect of piroxicam on the nephrotoxicity induced by ochratoxin A in rats. Toxicology 1995; 95: 147-54.
39. Schwerdt G, Freudinger R, Mildenberg S, Silbernagl S, Gekle M. The nephrotoxin ochratoxin A induces apoptosis in cultured human proximal tubule cells. Cell Biol Toxicol 1999; 15: 405-15.
40. Gekle M, Schwerdt G, Freudinger R, Mildenberg S, Wilflingseder D, Pollack V, Dander M, Schramek H. Ochratoxin A induces JNK activation and apoptosis in MDCK_C7 cells at nanomolar concentrations. J Pharmacol Exp Ther 2000; 293: 837-44.
41. Obrecht-Pflumio S, Grosse Y, Pfohl-Leszkowicz A, Dirheimer G. Protection by indomethacin and aspirin against genotoxicity of ochratoxin A, particularly in the urinary bladder and kidney. Arch Toxicol 1996; 70: 244-48.
42. Obrecht-Pflumio S, Chassat T, Dirheimer G, Marzin D. Genotoxicity of ochratoxin A by Salmonella mutagenicity test after bioactivation by mouse kidney microsomes. Mutat Res 1999; 446: 95-102.
43. Baudrimont I, Ahouandjivo R, Creppy EE. Prevention of lipid peroxidation induced by ochratoxin A in Vero cells in culture by several agents. Chem Biol Interact 1997; 104: 29-40.